Stat5 Activation Plays a Critical Role in Th2 Differentiation

Slides:



Advertisements
Similar presentations
Retinoic acid inhibits Th17 polarization and enhances FoxP3 expression through a Stat-3/Stat-5 independent signaling pathway by Kevin M. Elias, Arian Laurence,
Advertisements

Differentiation of CD4+ T Cells to Th1 Cells Requires MAP Kinase JNK2
Volume 136, Issue 4, Pages e3 (April 2009)
Volume 26, Issue 3, Pages (March 2007)
by Alexander Kiani, Francisco J
Inhibition of Th1 Differentiation by IL-6 Is Mediated by SOCS1
Wei Hu, Ty Dale Troutman, Ramakrishna Edukulla, Chandrashekhar Pasare 
Volume 27, Issue 4, Pages (October 2007)
Volume 34, Issue 3, Pages (March 2011)
Volume 31, Issue 2, Pages (August 2009)
Sequential Polarization and Imprinting of Type 1 T Helper Lymphocytes by Interferon-γ and Interleukin-12  Edda G. Schulz, Luca Mariani, Andreas Radbruch,
Volume 16, Issue 5, Pages (May 2002)
Volume 20, Issue 4, Pages (April 2004)
Volume 30, Issue 4, Pages (April 2009)
Volume 39, Issue 5, Pages (November 2013)
Volume 32, Issue 5, Pages (May 2010)
Volume 36, Issue 5, Pages (May 2012)
Volume 29, Issue 6, Pages (December 2008)
Volume 19, Issue 2, Pages (August 2003)
Volume 29, Issue 2, Pages (August 2008)
NKT Cells Inhibit the Onset of Diabetes by Impairing the Development of Pathogenic T Cells Specific for Pancreatic β Cells  Lucie Beaudoin, Véronique.
Volume 31, Issue 2, Pages (August 2009)
Volume 39, Issue 5, Pages (November 2013)
Volume 24, Issue 5, Pages (May 2006)
Volume 20, Issue 4, Pages (April 2004)
Volume 21, Issue 3, Pages (September 2004)
Volume 34, Issue 1, Pages (January 2011)
Volume 29, Issue 1, Pages (July 2008)
Volume 39, Issue 1, Pages (July 2013)
Liying Guo, Jane Hu-Li, William E. Paul  Immunity 
Probabilistic Regulation of IL-4 Production in Th2 Cells
Volume 36, Issue 3, Pages (March 2012)
Volume 27, Issue 1, Pages (July 2007)
Volume 24, Issue 2, Pages (February 2006)
Volume 19, Issue 5, Pages (November 2003)
Immunopathology in RSV Infection Is Mediated by a Discrete Oligoclonal Subset of Antigen-Specific CD4+ T Cells  Steven M Varga, Xiaoting Wang, Raymond.
Volume 36, Issue 6, Pages (June 2012)
Blimp-1 Transcription Factor Is Required for the Differentiation of Effector CD8+ T Cells and Memory Responses  Axel Kallies, Annie Xin, Gabrielle T.
Volume 32, Issue 5, Pages (May 2010)
Volume 9, Issue 5, Pages (November 1998)
Andrew T Miller, Heather M Wilcox, Zhongbin Lai, Leslie J Berg 
Volume 15, Issue 3, Pages (September 2001)
Volume 29, Issue 1, Pages (July 2008)
Opposing Effects of TGF-β and IL-15 Cytokines Control the Number of Short-Lived Effector CD8+ T Cells  Shomyseh Sanjabi, Munir M. Mosaheb, Richard A.
Volume 43, Issue 5, Pages (November 2015)
CTLA-4 Regulates Induction of Anergy In Vivo
Volume 15, Issue 2, Pages (August 2001)
Regulation of Expression of IL-4 Alleles
E3 Ubiquitin Ligase VHL Regulates Hypoxia-Inducible Factor-1α to Maintain Regulatory T Cell Stability and Suppressive Capacity  Jee H. Lee, Chris Elly,
Volume 37, Issue 6, Pages (December 2012)
Volume 126, Issue 6, Pages (September 2006)
Volume 32, Issue 5, Pages (May 2010)
Targeted Cleavage of Signaling Proteins by Caspase 3 Inhibits T Cell Receptor Signaling in Anergic T Cells  Irene Puga, Anjana Rao, Fernando Macian  Immunity 
Volume 30, Issue 4, Pages (April 2009)
Volume 28, Issue 1, Pages (January 2008)
Volume 28, Issue 5, Pages (May 2008)
Volume 33, Issue 1, Pages (July 2010)
Volume 35, Issue 4, Pages (October 2011)
Volume 38, Issue 2, Pages (February 2013)
Volume 11, Issue 21, Pages (October 2001)
Yunqi Wang, Maureen A. Su, Yisong Y. Wan  Immunity 
Volume 27, Issue 4, Pages (October 2007)
Volume 31, Issue 6, Pages (December 2009)
Volume 35, Issue 1, Pages (July 2011)
PU.1 Expression Delineates Heterogeneity in Primary Th2 Cells
Volume 32, Issue 5, Pages (May 2010)
Volume 24, Issue 6, Pages (June 2006)
Volume 14, Issue 3, Pages (March 2001)
Regulation of the Th2 Cytokine Locus by a Locus Control Region
Volume 37, Issue 4, Pages (October 2012)
Presentation transcript:

Stat5 Activation Plays a Critical Role in Th2 Differentiation Jinfang Zhu, Javier Cote-Sierra, Liying Guo, William E Paul  Immunity  Volume 19, Issue 5, Pages 739-748 (November 2003) DOI: 10.1016/S1074-7613(03)00292-9

Figure 1 STAT5A1*6 Restores IL-4 Production in Cells Primed under Th2 Conditions in the Absence of IL-2 Naive line 94 CD4 T cells were activated with APC and PCC peptide under Th2 conditions for 40 hr and infected with STAT5A1*6-NGFR-RV or NGFR-RV in the presence or absence of anti-IL-2. After an additional 4 day culture under Th2 conditions, cells were washed and stimulated with PMA and ionomycin for 4 hr in the presence of monensin. Cells were fixed, permeabilized, and stained for IL-4, IFNγ, and NGFR expression. The dot plots were gated on NGFR+ cells. Data are representative of three independent experiments. Immunity 2003 19, 739-748DOI: (10.1016/S1074-7613(03)00292-9)

Figure 2 Cells Infected with STAT5A1*6-NGFR-RV under ThN or Th1 Conditions Produce IL-4 (A) C57BL/6 CD4 T cells were activated with APC and soluble anti-CD3/anti-CD28 under Th1 conditions for 40 hr and infected with STAT5A1*6-NGFR-RV or NGFR-RV. They were then cultured for an additional 4 days under Th1 conditions. (B) Line 94 CD4 T cells were activated with APC and PCC under Th1 conditions for 40 hr and infected with STAT5A1*6-NGFR-RV. They were then labeled with CFSE 24 hr later and cultured for an additional 3 days under Th1 conditions. (C) Line 94 CD4 T cells were activated under ThN, Th1, or Th2 conditions for 40 hr. A portion of the cells were infected with the STAT5A1*6-NGFR-RV (St5); the remainder of the cells were not infected (un). They were then cultured for an additional 4 days under continuous ThN, Th1, or Th2 conditions. (D) STAT5A1*6-NGFR-RV infected or noninfected cells primed under Th1 or Th2 conditions, prepared in (C), were further activated under continuous Th1 or Th2 conditions for an additional 4 days after a 2 day culture in IL-2-containing medium. The percentage of cytokine-producing cells in the STAT5A1*6-NGFR-RV-infected group was calculated based on the proportion of NGFR+ cells that stained for IL-4 and/or IFNγ. Immunity 2003 19, 739-748DOI: (10.1016/S1074-7613(03)00292-9)

Figure 3 Stat6−/− and IL-4Rα−/− Cells Infected with STAT5A1*6-NGFR-RV Produce IL-4 (A) Stat6−/− or +/+ C57BL/6 CD4 T cells were activated with APC and soluble anti-CD3/anti-CD28 under ThN, Th1, or Th2 conditions for 40 hr. (B) Naive IL-4Rα−/− or +/+ DO11.10 Rag2−/− CD4 T cells were activated with APC and OVA peptide under ThN or Th2 conditions for 40 hr. A portion of the cells were infected with the STAT5A1*6-NGFR-RV (St5); the remainder of the cells were not infected (un). After an additional 4 day culture under continuous ThN, Th1, orTh2 conditions, IL-4 production and NGFR expression was determined in cells stimulated with PMA and ionomycin. The percentage of IL-4-producing cells in the STAT5A1*6-NGFR-RV-infected group was calculated based on the proportion of NGFR+ cells. Immunity 2003 19, 739-748DOI: (10.1016/S1074-7613(03)00292-9)

Figure 4 Cells Infected with the STAT5A1*6-NGFR-RV under ThN or Th1 Conditions Do Not Express High Levels of GATA-3 Line 94 CD4 T cells were activated under ThN, Th1, or Th2 conditions for 40 hr. A portion of the cells were infected with the STAT5A1*6-NGFR-RV (St5); the remainder of the cells were not infected. After an additional 4 day culture under ThN, Th1, or Th2 conditions, cells were sorted based on the staining for NGFR (St5). (A) Sorted cells were then restimulated with PMA and ionomycin for 2 hr, and real-time RT-PCR for GATA-3 and T-bet mRNA was carried out. Relative amounts of GATA-3 in Th1 cells and T-bet in Th2 cells are assigned a value of 1. (B) Intracellular staining for GATA-3 was carried out. Similar results were obtained in two independent experiments. Immunity 2003 19, 739-748DOI: (10.1016/S1074-7613(03)00292-9)

Figure 5 STAT5A1*6 and GATA-3 Have Similar but Distinct Roles in Th1 and Th2 Cytokine Production Line 94 CD4 T cells were activated under ThN, Th1, or Th2 conditions for 40 hr. A portion of the cells were infected with the STAT5A1*6-NGFR-RV (St5) or the GATA-3-GFP-RV (Gata3); the remaining cells were not infected. After an additional 4 day culture under ThN, Th1, or Th2 conditions, cells were sorted for NGFR (STAT5A1*6) or GFP expression (GATA-3). Sorted cells were then restimulated with PMA and ionomycin for 2 hr (P/I), and total RNA was prepared. RPA was then carried out using the mCK-1 panel. Immunity 2003 19, 739-748DOI: (10.1016/S1074-7613(03)00292-9)

Figure 6 Coinfection with STAT5A1*6-NGFR-RV and GATA-3-GFP-RV Optimizes IL-4 Production Line 94 CD4 T cells were activated with APC and PCC under ThN or Th1 conditions for 40 hr and coinfected with the STAT5A1*6-NGFR-RV and the GATA-3-GFP-RV. After an additional 4 day culture under ThN or Th1 conditions, they were stimulated with PMA and ionomycin. Staining for IL-4 and for NGFR expression was carried out. (A) Dot plots were gated on NGFR+ (St5-NGFR+) and NGFR− (St5-NGFR−) populations. (B) Percent of IL-4-producing cells in each infected group was calculated. (C) MFIs of IL-4 from positive cells in each group are presented. Data are representative of two similar experiments. Immunity 2003 19, 739-748DOI: (10.1016/S1074-7613(03)00292-9)

Figure 7 STAT5A1*6 and GATA-3 Open Different Sites in the Il4 Gene Line 94 CD4 T cells were activated under Th1 or Th2 conditions for 40 hr; Th1 cells were infected with the STAT5A1*6-NGFR-RV (St5) or the GATA-3-GFP-RV (Gata3) or both. After an additional 4 day culture under Th1 or Th2 conditions, cells were washed and cultured in IL-2 for 2 days. They were then restimulated with APC and peptide under Th1 or Th2 conditions for an additional two rounds; each round consisted of 4 days of priming and 2 days in IL-2. Cells were then sorted based on the staining for NGFR (STAT5A1*6) or GFP expression (GATA-3). (A) REAs for HSII, HSIII, CNS-1, and VA were carried out. Relative accessibility of all sites to β-actin in Th1 cells was assigned a value of 1. (B) STAT5A1*6-NGFR-RV-infected Th1 cells were fixed, lysed, and sonicated. Samples were then immunoprecipitated with anti-Stat5A or control rabbit serum. The input and precipitated DNA were purified, and the amount of DNA sequences derived from HSII, HSIII, VA, S3PS, and T-bet 3′UTR was assessed by real-time PCR. Relative enrichment was calculated based on the amount of the sequence compared to that of the control sequence derived from T-bet 3′UTR. Data are representative of two similar experiments. Immunity 2003 19, 739-748DOI: (10.1016/S1074-7613(03)00292-9)